Cancer-associated mesenchymal stem cells aggravate tumor progression

Frontiers in Cell and Developmental Biology

Volumn 3, Issue APR, 2015, Pages

  Kudo Saito, Chie ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer; Epithelial to mesenchymal transition; Immunosuppression; Mesenchymal stem cell; Metastasis

Indexed keywords

EID: 84933546151     PISSN: None     EISSN: 2296634X     Source Type: Journal    
DOI: 10.3389/fcell.2015.00023     Document Type: Article

References (41)

1. Bergfeld, S. A., and Declerck, Y. A. (2010). Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev. 29, 249-261. doi: 10.1007/s10555-010-9222-7
2. Burr, S. P., Dazzi, F., and Garden, O. A. (2013). Mesenchymal stromal cells and regulatory T cells: the Yin and Yang of peripheral tolerance? Immunol. Cell Biol. 91, 12-18. doi: 10.1038/icb.2012.60
3. De Palma, M., and Naldini, L. (2011). Angiopoietin-2 TIEs up macrophages in tumor angiogenesis. Clin. Cancer Res. 17, 5226-5232. doi: 10.1158/1078-0432.CCR-10-0171
4. English, K. (2013). Mechanisms of mesenchymal stromal cell immunomodulation. Immunol. Cell Biol. 91, 19-26. doi: 10.1038/icb.2012.56
5. Fagiani, E., and Christofori, G. (2013). Angiopoietins in angiogenesis. Cancer Lett. 328, 18-26. doi: 10.1016/j.canlet.2012.08.018
6. Faurobert, E., Bouin, A. P., and Albiges-Rizo, C. (2015). Microenvironment, tumor cell plasticity, and cancer. Curr. Opin. Oncol. 27, 64-70. doi: 10.1097/CCO.0000000000000154
7. Giuliani, M., Fleury, M., Vernochet, A., Ketroussi, F., Clay, D., Azzarone, B., et al. (2011). Long-lasting inhibitory effects of fetal liver mesenchymal stem cells on T-lymphocyte proliferation. PLoS ONE 6:e19988. doi: 10.1371/journal.pone.0019988
8. Jung, Y., Kim, J. K., Shiozawa, Y., Wang, J., Mishra, A., Joseph, J., et al. (2013). Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis. Nat. Commun. 4:1795. doi: 10.1038/ncomms2766
9. Junttila, M. R., and De Sauvage, F. J. (2013). Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501, 346-354. doi: 10.1038/nature12626
10. Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., et al. (2007). Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557-563. doi: 10.1038/nature06188
11. Kudo-Saito, C. (2013). FSTL1 promotes bone metastasis by causing immune dysfunction. Oncoimmunology 2:e26528. doi: 10.4161/onci.26528
12. Kudo-Saito, C., Fuwa, T., Murakami, K., and Kawakami, Y. (2013a). Targeting FSTL1 prevents tumor bone metastasis and consequent immune dysfunction. Cancer Res. 73, 6185-6193. doi: 10.1158/0008-5472.CAN-13-1364
13. Kudo-Saito, C., Shirako, H., Ohike, M., Tsukamoto, N., and Kawakami, Y. (2013b). CCL2 is critical for immunosuppression to promote cancer metastasis. Clin. Exp. Metastasis 30, 393-405. doi: 10.1007/s10585-012-9545-6
14. Kudo-Saito, C., Shirako, H., Takeuchi, T., and Kawakami, Y. (2009). Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 15, 195-206. doi: 10.1016/j.ccr.2009.01.023
15. Kudo-Saito, C., Yura, M., Yamamoto, R., and Kawakami, Y. (2014). Induction of immunoregulatory CD271+ cells by metastatic tumor cells that express human endogenous retrovirus H. Cancer Res. 74, 1361-1370. doi: 10.1158/0008-5472.CAN-13-1349
16. Kuhn, N. Z., and Tuan, R. S. (2010). Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. J. Cell. Physiol. 222, 268-277. doi: 10.1002/jcp.21940
17. Liu, Z. J., Zhuge, Y., and Velazquez, O. C. (2009). Trafficking and differentiation of mesenchymal stem cells. J. Cell. Biochem. 106, 984-991. doi: 10.1002/jcb.22091
18. Lu, Y., Chen, Q., Corey, E., Xie, W., Fan, J., Mizokami, A., et al. (2009). Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone. Clin. Exp. Metastasis 26, 161-169. doi: 10.1007/s10585-008-9226-7
19. Luo, J., Ok Lee, S., Liang, L., Huang, C. K., Li, L., Wen, S., et al. (2014). Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling. Oncogene 33, 2768-2778. doi: 10.1038/onc.2013.233
20. Maggini, J., Mirkin, G., Bognanni, I., Holmberg, J., Piazzon, I. M., Nepomnaschy, I., et al. (2010). Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS ONE 5:e9252. doi: 10.1371/journal.pone.0009252
21. Minami, T., Jiang, S., Schadler, K., Suehiro, J., Osawa, T., Oike, Y., et al. (2013). The calcineurin-NFAT-angiopoietin-2 signaling axis in lung endothelium is critical for the establishment of lung metastases. Cell Rep. 4, 709-723. doi: 10.1016/j.celrep.2013.07.021
22. Miura, M., Miura, Y., Padilla-Nash, H. M., Molinolo, A. A., Fu, B., Patel, V., et al. (2006). Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 24, 1095-1103. doi: 10.1634/stemcells.2005-0403
23. Mohseny, A. B., and Hogendoorn, P. C. (2011). Concise review: mesenchymal tumors: when stem cells go mad. Stem Cells 29, 397-403. doi: 10.1002/stem.596
24. Nauta, A. J., and Fibbe, W. E. (2007). Immunomodulatory properties of mesenchymal stromal cells. Blood 110, 3499-3506. doi: 10.1182/blood-2007-02-069716
25. Prevosto, C., Zancolli, M., Canevali, P., Zocchi, M. R., and Poggi, A. (2007). Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. Haematologica 92, 881-888. doi: 10.3324/haematol.11240
26. Rappa, G., Mercapide, J., and Lorico, A. (2012). Spontaneous formation of tumorigenic hybrids between breast cancer and multipotent stromal cells is a source of tumor heterogeneity. Am. J. Pathol. 180, 2504-2515. doi: 10.1016/j.ajpath.2012.02.020
27. Rigamonti, N., and De Palma, M. (2013). A role for angiopoietin-2 in organ-specific metastasis. Cell Rep. 4, 621-623. doi: 10.1016/j.celrep.2013.07.034
28. Roodhart, J. M., Daenen, L. G., Stigter, E. C., Prins, H. J., Gerrits, J., Houthuijzen, J. M., et al. (2011). Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids. Cancer Cell 20, 370-383. doi: 10.1016/j.ccr.2011.08.010
29. Rosland, G. V., Svendsen, A., Torsvik, A., Sobala, E., McCormack, E., Immervoll, H., et al. (2009). Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res. 69, 5331-5339. doi: 10.1158/0008-5472.CAN-08-4630
30. Schlecker, E., Stojanovic, A., Eisen, C., Quack, C., Falk, C. S., Umansky, V., et al. (2012). Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth. J. Immunol. 189, 5602-5611. doi: 10.4049/jimmunol.1201018
31. Spaeth, E. L., Labaff, A. M., Toole, B. P., Klopp, A., Andreeff, M., and Marini, F. C. (2013). Mesenchymal CD44 expression contributes to the acquisition of an activated fibroblast phenotype via TWIST activation in the tumor microenvironment. Cancer Res. 73, 5347-5359. doi: 10.1158/0008-5472.CAN-13-0087
32. Sylva, M., Moorman, A. F., and Van Den Hoff, M. J. (2013). Follistatin-like 1 in vertebrate development. Birth Def. Res. (Part C) 99, 61-69. doi: 10.1002/bdrc.21030
33. Tan, M. C., Goedegebuure, P. S., Belt, B. A., Flaherty, B., Sankpal, N., Gillanders, W. E., et al. (2009). Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer. J. Immunol. 182, 1746-1755. doi: 10.4049/jimmunol.182.3.1746
34. Tang, C. H., and Tsai, C. C. (2012). CCL2 increases MMP-9 expression and cell motility in human chondrosarcoma cells via the Ras/Raf/MEK/ERK/NF-kappaB signaling pathway. Biochem. Pharmacol. 83, 335-344. doi: 10.1016/j.bcp.2011.11.013
35. Tolar, J., Nauta, A. J., Osborn, M. J., Panoskaltsis Mortari, A., McElmurry, R. T., Bell, S., et al. (2007). Sarcoma derived from cultured mesenchymal stem cells. Stem cells 25, 371-379. doi: 10.1634/stemcells.2005-0620
36. Torres, S., Bartolome, R. A., Mendes, M., Barderas, R., Fernandez-Acenero, M. J., Pelaez-Garcia, A., et al. (2013). Proteome profiling of cancer-associated fibroblasts identifies novel proinflammatory signatures and prognostic markers for colorectal cancer. Clin. Cancer Res. 19, 6006-6019. doi: 10.1158/1078-0432.CCR-13-1130
37. Uccelli, A., Moretta, L., and Pistoia, V. (2008). Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 8, 726-736. doi: 10.1038/nri2395
38. Weidle, U. H., Eggle, D., Klostermann, S., and Swart, G. W. (2010). ALCAM/CD166: cancer-related issues. Cancer Genomics Proteomics 7, 231-243
39. Weilbaecher, K. N., Guise, T. A., and McCauley, L. K. (2011). Cancer to bone: a fatal attraction. Nature reviews. Cancer 11, 411-425. doi: 10.1038/nrc3055
40. Xu, M. H., Gao, X., Luo, D., Zhou, X. D., Xiong, W., and Liu, G. X. (2014). EMT and acquisition of stem cell-like properties are involved in spontaneous formation of tumorigenic hybrids between lung cancer and bone marrow-derived mesenchymal stem cells. PLoS ONE 9:e87893. doi: 10.1371/journal.pone.0087893
41. Yang, X., Hou, J., Han, Z., Wang, Y., Hao, C., Wei, L., et al. (2013). One cell, multiple roles: contribution of mesenchymal stem cells to tumor development in tumor microenvironment. Cell Biosci. 3:5. doi: 10.1186/2045-3701-3-5